Background/objectives： Disorder of energy homeostasis can lead to a variety of metabolic diseases, 14 especially obesity. Brown adipose tissue (BAT) is a promising potential therapeutic target for the 15 treatment of obesity and related metabolic diseases. Allicin, a main bioactive ingredient in garlic, has 16 multiple biology and pharmacological function. However, the role of Allicin, in the regulation of 17 metabolic organ, especially the role of activation of BAT, has not been well studied. Here, we 18 analyzed the role of Allicin in whole-body metabolism and the activation of BAT.
Introduction 40
The regulation of energy homeostasis, including food intake, energy expenditure, and body 41 adiposity, is crucial for the health of the body (1, 2). Obesity is a result of unbalance of energy 42 homeostasis which caused by energy intake exceeds energy expenditure, and then excess 43 energy stored in fat in the form of triglycerides which lead to adiposity(3) and can cause a 44 series of metabolic diseases, such as insulin resistance, type 2 diabetes mellitus cardiovascular 45 disease, cancer, inflammation and other related diseases(4). Currently, obesity has become 46 one of the fastest-growing non-communicable diseases, and it estimated that by 2030, 38% of 47 adults would be overweight and 20% will develop obesity in the world (5, 6) . Although the 48 situation of obesity is dire, satisfactory safe and effective treatment strategies are limited for 49 individuals (7) . 50
There are two main types of fat in mammals, including energy-storing white adipose 51 tissues (WAT) and energy-consuming brown adipose tissues (BAT) (8). Different from WAT, 52
BAT contains a large number of mitochondria which is responsible for nonshivering 53 thermogenesis in mammals(9, 10). Increasing studies showed that the potential therapy of 54
anti-obesity and related metabolic diseases are related to the activation of BAT, which bring a 55 new way to fight obesity (11) (12) (13) (14) . Besides, the proper stimulus could induce the generation of 56 UCP1 (uncoupling protein-1) in WAT, which is also rich in mitochondria and defined as 57
beiging (15). Many studies suggested that beiging in WAT also can effectively enhance 58 energy expenditure and improve metabolic disorder (16, 17) . Furthermore, reducing the 59 amount of WAT and the size of white adipocyte can effectively improve inflammation and 60 metabolic disorders (18). Both WAT and BAT have essential functions in regulating energy 61 homeostasis. Therefore, increasing activation of BAT and induction of beiging in WAT could 62 be an effective therapeutic strategy for obesity and its related diseases. 63
Allicin, a main bioactive ingredient in garlic(19), has multiple pharmacological functions, 64
including anti-oxidative stress, anti-tumor, cholesterol-lowering, anti-platelet aggregation, 65 liver protection, prevention of cardiovascular disease and anti-inflammatory (20-22). 66
Although Allicin induces beiging in WAT(23), the effect of the regulation of energy 67 homeostasis including whole-body energy metabolism and the mechanism of activation of 68
BAT of Allicin is still unclear. 69
In this study, we determined the effect of the whole-body energy metabolism and activating 70
BAT of Allicin.Our data establish that Allicin plays a previously not fully recognized role in 71
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137

Brown adipocyte differentiation 138
The isolation method of mouse BAT primary cells referred to(26). Primary cells were cultured in 139 basal medium (containing 80% DMEM, 20% fetal bovine serum, and 1% penicillin and streptomycin) 140 until the cells had reached more than 90% confluency. Then, cells were treated with a brown We used a single-factor analysis of variance (ANOVA) followed by a two-tailed Student's t-test 181 for comparisons. We presented almost all data as means ± SEM. Significant differences were 182 considered when P < 0.05.
184
Result 185
Allicin reduces adiposity and maintains glucose homeostasis in mice 186
To investigate the effect of allicin on energy homeostasis, the high-fat-diet-induced 187 obesity mice model (HFD) and genetically leptin-receptor-deficiency obese (Db/Db) mice 188
model was used to assess the role of Allicin on obesity and energy metabolism. Firstly, we 189 screened the optimal treatment concentration (Allicin-high) of allicin by observing the effect 190
of three doses of allicin on the reduction of body weight of HFD mice ( Fig. 1A and Fig. s1B ) 191
and also treated the Db/Db mice with the optimal concentration. A significant reduction in 192 body weight after Allicin treatment was observed both in HFD and Db/Db mice models ( Fig.  193 1A-1B, Fig. 2A-2C) . Notably, the protection from weight gain after Allicin treatment mainly 194
due to the reduction of fat accumulation in eWAT and sWAT ( Fig. 1C-1E , Fig. 2D and 2E ). and NEFA levels, were also markedly reduced after Allicin treatment ( Fig. s4 ). Taken 202 together, these results indicated that Allicin notably ameliorates adiposity and maintains 203 glucose homeostasis in mice. 204
Allicin augments whole-body energy expenditure by activation of brown adipose tissue 205
Energy consumption is an essential indicator of assessing energy homeostasis. We next 206
investigated the effect of Allicin on whole-body energy expenditure in HFD and Db/Db mice 207
with the respiratory metabolic system. We found that Allicin markedly increased the oxygen 208 consumption both in HFD and Db/Db mice ( Fig. 3A-3C , Fig. 4A and 4B) , indicating that 209
Allicin-treated group mice have a higher energy expenditure. However, there is no significant 210 difference in physical activity, food intake, or water intake ( Fig. 3D-3E, Fig. S2 ). Besides, 211
Allicin treatment significantly increased the thermogenesis of interscapular BAT site and 212 rectal temperature after cold stimulation in all Allicin treatment groups compared with the 213 control group both in HFD and Db/Db mice ( Fig. 3G and 3H, Fig. 4C and 4D) . BAT is well 214 known as an essential thermogenic and energy-consuming organ in the body, maintaining the 215 body temperature by non-shaking thermogenesis under the stimuli of cold. Based on the 216 above results，we hypothesized that Allicin augments whole-body energy expenditure by 217 activation of BAT in HFD and Db/Db mice. Expectedly, Allicin treatment significantly 218 induced the expression of genes related to thermogenesis and energy expenditure, including 219 UCP1, PRDM16, PGC1α/β, CPT1α, and MCAD, in the BAT from HFD mice (Fig. 3I) . 220
Meanwhile, the 18F-fluorodeoxyglucose(FDG) PET combined with X-ray CT analysis shows 221 that Allicin treatment dramatically increased the glucose utilization rate both in HFD and 222
Db/Db mice ( Fig.. 3J and 3K, Fig. 4E and 4F ). Histological analysis of BAT indicates that 223
allicin treatment can reduce the size of lipid droplet ( Fig. 2F and Fig. 4G ). The 224
immunoblotting analysis further indicated that Allicin significantly enhanced the UCP1 and 225
OXPHPS-related proteins (ATP5A, UQCRC2, SDHB, and NDUFB8) expression in BAT 226
both from HFD and Db/Db mouse ( Fig. 3L and Fig. 4H ). These results strongly indicated that 227
that Allicin dramatically increased BAT activity in the HFD and Db/Db mice. These results 228
altogether confirm that Allicin treatment increased whole-body energy expenditure and 229
reduced adiposity in the mice. 230
Allicin active the brown adipocytes and increase the energy expenditure in vitro. 231
The above results have proved that Allicin can increase energy expenditure through the 232 activation of BAT in vivo. However, it is unclear whether allicin activates brown fat as a 233 direct or indirect effect. In order to Fig. out this question, we isolated brown primary 234 adipocytes from mice and performed an in vitro brown adipocytes differentiation assay with 235 and/or without Allicin treatment. As the results, Allicin increased the expression of UCP1, the 236 golden maker of activation of BAT, in a dose-dependent manner and with best activation 237 effect at a concentration of 50 μM (Fig. 5A ). Consistently, the thermogenic genes, including 238
PGC1α/β and CPT1α/β were also upregulated after the Allicin treatment compared with the 239 solvent treatment (Fig. 5B) . Besides, UCP1 levels were further confirmed by quantification of 240 the protein expression by immunoblotting and immunostaining ( Fig. 5C and 5D ). 241
Furthermore, the expression levels of OXPHOS proteins, including ATP5A, UQCRC2, 242 SDHB, and NDUFB8, were markedly upregulated after Allicin treatment compared with the 243 solvent treatment (Fig. 5D) . Importantly, the effect of Allicin on energy expenditure were 244 accessed by an oxygen consumption rate (OCR) in brown adipocytes. Expectedly, the OCR-245 related basal metabolic rate, ATP levels, maximum oxygen consumption, and proton leakage 246
were all markedly increased after Allicin treatment compared with solvent treatment (Fig. 5E-247  4I) . Notably, we also investigated the effect of Allicin on activation of brown adipocytes in 248 human brown adipocytes. Surprisingly, the expression levels of thermogenic genes including 249 UCP1, PGC1α/β, and CPT1α/β were dramatically increased after the brown adipocyte 250 differentiation cocktail medium treatment with Allicin compared with solvent ( Fig. s5A ). 251
Correspondingly, the UCP1 levels in human brown adipocytes were further confirmed by 252
immunoblotting and immunostaining ( Fig. s5D and s5E) . Meanwhile, the expression levels of 253 OXPHOS proteins in human brown adipocytes also were significantly upregulated after 254
Allicin treatment compared with the solvent treatment (Fig. s5E) . The human brown 255
adipocytes results indicated that Allicin also has the potential to be applied to human 256 metabolic disease. Collectively, these results indicate that Allicin can active brown adipocytes 257
and increase the energy expenditure in vitro. 258 259
Discussion 260
Metabolic diseases caused by the unbalance of energy homeostasis are an explosive 261 epidemic, especially obesity, and related metabolic diseases (27). BAT is a critical organ that 262
regulates energy homeostasis and known as an important potential target for the treatment of 263 metabolic diseases. Bioactive compounds in food have attracted much attention as a safe and 264 effective molecular library. It has reported that garlic is an excellent natural source of 265 bioactive compounds(28). In this study, we revealed that the beneficial effects of Allicin on 266 energy homeostasis in obese mice. Our data show that allicin enhances the BAT function, 267
promotes the energy expenditure, inhibits the fat mass accumulation, improves the glucose 268 homeostasis and insulin sensitivity, and improve hepatic steatosis. Mechanisms, we found 269
that Allicin can induce the promote the activity of sirt1 and induce the downstream PGC1α-270
Tfam signaling pathway. It is the first study that relatively systematically demonstrated that 271
Allicin induces BAT activation and regulate energy homeostasis. Our findings point out that 272
reasonable proper administration of Allicin may be a promising potential therapeutic strategy 273
for obesity and related metabolic syndromes. 274
Allicin (thio-2-propene-1-sulfinic acid S-allyl ester) is the principal component of garlic and has 275 many physiological functions. Several studies have reported that garlic or its main ingredient, 276
allicin, has an anti-obesity ， anti-hyperinsulinemic, anti-hyperlipidemic, and anti-277 hypertensive effect (23, 29-31). Among them, a research article reported that Allicin could 278
induce brown-like adipogenesis and increased lipid oxidation in subcutaneous fat though 279 KLF15 signal cascade (23). However, the effect and mechanism of Allicin on the BAT 280 functions has remained unclear. Additionally, the research of Allicin on regulating energy 281 homeostasis is not systematic. In the present study, our findings demonstrated that Allicin 282
induced BAT activation, leading to the inhibition of obesity and maintain energy homeostasis 283 in mice. 284
The malfunctions of energy homeostasis, including energy expenditure (EE), food intake, 285
and fat hypertrophy, can cause obesity (1, 2). In the current study, Allicin treatment 286
profoundly increased the energy expenditure, reduced fat mass, body weight gain, and 287
improved the glucose homeostasis in HFD mice. Importantly, the similar effect of allicin was 288 further confirmed in DB/DB mice, which is a leptin receptor-deficient genetic obese mice 289
model. This indicates that Allicin has a stable function of preventing and treating obesity and 290
regulating energy metabolism of the body. Furthermore, we investigated the effect of Allicin 291 on BAT activation both in HFD and DB/DB mice and found that Allicin treatment more 292
profoundly promotes the activation of BAT in Db/Db mice than in HFD mice( Fig. 3 and Fig.  293  4) , based on that Db/Db mice are known to deficient in BAT activity(32, 33). This result 294
indicated that Allicin has excellent ability to activate BAT and regulate energy metabolism. 295
However, there are many factors (including thyroid hormones, catecholamine 296 neurotransmission, and cytokines) secreted by the endocrine system, which can activate 297 brown adipocyte. So, in order to determine the effect of allicin on BAT activation is direct or 298 secondary, we performed the Allicin treatment on brown adipocytes in vitro. Our data of 299
Allicin treatment in vitro confirmed that Allicin could directly activate the brown adipocyte. 300
In summary, the present study demonstrated that allicin regulates energy homeostasis 301 through promoting BAT activation. In general, moderate application of Allicin 302 represents a promising potential treatment strategy for prevention of obesity and 303 related metabolic disorder. 
